** Shares of Daré Bioscience DARE.O rise ~21.7% to 55
cents
** Co says it will receive a milestone payment of $1.8 mln
from Organon OGN.N in connection with the first commercial
sale of its gel XACIATO for bacterial vaginosis
** Co is eligible to receive potential future milestone
payments of up to $180 mln and tiered double-digit royalties
based on net sales of the gel
** Bacterial vaginosis is a condition that happens when
there is too much of certain bacteria in the vagina
** Including session moves, shares down 33.7% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))